130 related articles for article (PubMed ID: 33926738)
1. Neprilysin and Corin in HF: Does Combining 2 Biomarkers Double Our Insights?
Gladysheva IP; Sullivan RD; Reed GL
JACC Heart Fail; 2021 May; 9(5):406. PubMed ID: 33926738
[No Abstract] [Full Text] [Related]
2. Reply: Neprilysin and Corin in HF: Does Combining 2 Biomarkers Double Our Insights?
Gommans DHF; Revuelta-Lopez E; Bayés-Genis A; van Kimmenade RRJ
JACC Heart Fail; 2021 May; 9(5):407-408. PubMed ID: 33926740
[No Abstract] [Full Text] [Related]
3. Soluble Neprilysin and Corin Concentrations in Relation to Clinical Outcome in Chronic Heart Failure.
Gommans DHF; Revuelta-Lopez E; Lupon J; Cserkóová A; Domingo M; Vart P; van Royen N; Bayés-Genis A; van Kimmenade RRJ
JACC Heart Fail; 2021 Feb; 9(2):85-95. PubMed ID: 33189629
[TBL] [Abstract][Full Text] [Related]
4. Neprilysin and Corin: It Takes Two to Tango.
Myhre PL; Vaduganathan M; Solomon SD
JACC Heart Fail; 2021 Feb; 9(2):96-99. PubMed ID: 33189628
[No Abstract] [Full Text] [Related]
5. Soluble Neprilysin, Corin Concentrations, and Clinical Outcome in Chronic Heart Failure: The miRNAs Role.
Patanè S
JACC Heart Fail; 2021 May; 9(5):407. PubMed ID: 33926739
[No Abstract] [Full Text] [Related]
6. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
Tripathi R; Wang D; Sullivan R; Fan TH; Gladysheva IP; Reed GL
Hypertension; 2016 Feb; 67(2):362-7. PubMed ID: 26667411
[TBL] [Abstract][Full Text] [Related]
7. Cardiac-Specific Overexpression of Catalytically Inactive Corin Reduces Edema, Contractile Dysfunction, and Death in Mice with Dilated Cardiomyopathy.
Tripathi R; Sullivan RD; Fan TM; Houng AK; Mehta RM; Reed GL; Gladysheva IP
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892216
[TBL] [Abstract][Full Text] [Related]
8. BNP molecular forms and processing by the cardiac serine protease corin.
Ichiki T; Huntley BK; Burnett JC
Adv Clin Chem; 2013; 61():1-31. PubMed ID: 24015598
[TBL] [Abstract][Full Text] [Related]
9. Plasma corin decreases after coronary artery bypass graft surgery and is associated with postoperative heart failure: a pilot study.
Barnet CS; Liu X; Body SC; Collard CD; Shernan SK; Muehlschlegel JD; Jarolim P; Fox AA
J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):374-81. PubMed ID: 25649697
[TBL] [Abstract][Full Text] [Related]
10. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
[TBL] [Abstract][Full Text] [Related]
11. Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
Nougué H; Pezel T; Picard F; Sadoune M; Arrigo M; Beauvais F; Launay JM; Cohen-Solal A; Vodovar N; Logeart D
Eur J Heart Fail; 2019 May; 21(5):598-605. PubMed ID: 30520545
[TBL] [Abstract][Full Text] [Related]
12. Regulated inositol-requiring protein 1-dependent decay as a mechanism of corin RNA and protein deficiency in advanced human systolic heart failure.
Lee R; Xu B; Rame JE; Felkin LE; Barton P; Dries DL
J Am Heart Assoc; 2014 Dec; 3(6):e001104. PubMed ID: 25516437
[TBL] [Abstract][Full Text] [Related]
13. Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD).
Claus R; Berliner D; Bavendiek U; Vodovar N; Lichtinghagen R; David S; Patecki M; Launay JM; Bauersachs J; Haller H; Hiss M; Balzer MS
Clin Res Cardiol; 2020 Aug; 109(8):1035-1047. PubMed ID: 32002632
[TBL] [Abstract][Full Text] [Related]
14. Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy.
Maisel AS; Daniels LB; Anand IS; McCullough PA; Chow SL
Postgrad Med; 2018 Apr; 130(3):299-307. PubMed ID: 29596012
[TBL] [Abstract][Full Text] [Related]
15. Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure.
Vodovar N; Séronde MF; Laribi S; Gayat E; Lassus J; Januzzi JL; Boukef R; Nouira S; Manivet P; Samuel JL; Logeart D; Cohen-Solal A; Richards AM; Launay JM; Mebazaa A;
JACC Heart Fail; 2015 Aug; 3(8):629-36. PubMed ID: 26251090
[TBL] [Abstract][Full Text] [Related]
16. Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.
Bayés-Genís A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2015 Feb; 65(7):657-65. PubMed ID: 25677426
[TBL] [Abstract][Full Text] [Related]
17. Putting Together the Pieces of the Natriuretic Peptide Puzzle.
Gommans DH; Bayés-Genís A; van Kimmenade RR
JACC Heart Fail; 2016 Aug; 4(8):670-3. PubMed ID: 27395344
[No Abstract] [Full Text] [Related]
18. Interpretation of B-type natriuretic peptides in the era of angiotensin receptor-neprilysin inhibitors.
Bettencourt P; Fonseca C; Franco F; Andrade A; Brito D
Rev Port Cardiol; 2017 Dec; 36(12):881-884. PubMed ID: 29225105
[TBL] [Abstract][Full Text] [Related]
19. Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF).
Januzzi JL; Butler J; Fombu E; Maisel A; McCague K; Piña IL; Prescott MF; Riebman JB; Solomon S
Am Heart J; 2018 May; 199():130-136. PubMed ID: 29754651
[TBL] [Abstract][Full Text] [Related]
20. Neprilysin in Heart Failure: From Oblivion to Center Stage.
Bayés-Genís A
JACC Heart Fail; 2015 Aug; 3(8):637-40. PubMed ID: 26251091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
